1. Home
  2. TIRX vs BRTX Comparison

TIRX vs BRTX Comparison

Compare TIRX & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TIAN RUIXIANG Holdings Ltd

TIRX

TIAN RUIXIANG Holdings Ltd

HOLD

Current Price

$0.08

Market Cap

8.2M

Sector

Finance

ML Signal

HOLD

Logo BioRestorative Therapies Inc. (NV)

BRTX

BioRestorative Therapies Inc. (NV)

HOLD

Current Price

$0.23

Market Cap

9.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TIRX
BRTX
Founded
2010
1997
Country
China
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Managed Health Care
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.2M
9.3M
IPO Year
2019
2015

Fundamental Metrics

Financial Performance
Metric
TIRX
BRTX
Price
$0.08
$0.23
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
99.2M
5.3M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
66.08
EPS
N/A
N/A
Revenue
N/A
$81,000.00
Revenue This Year
N/A
$24.64
Revenue Next Year
N/A
$287.76
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.04
$0.19
52 Week High
$3.45
$2.10

Technical Indicators

Market Signals
Indicator
TIRX
BRTX
Relative Strength Index (RSI) 41.76 18.82
Support Level $0.07 N/A
Resistance Level $0.99 $1.22
Average True Range (ATR) 0.02 0.08
MACD 0.01 -0.02
Stochastic Oscillator 30.60 4.44

Price Performance

Historical Comparison
TIRX
BRTX

About TIRX TIAN RUIXIANG Holdings Ltd

Tian Ruixiang Holdings Ltd is an Insurance Brokerage firm. It distributes a wide range of insurance products, which are categorized into two groups; property and casualty insurance, such as commercial property insurance, liability insurance, accidental insurance, and automobile insurance; and other insurances, such as health insurance, life insurance, and miscellaneous insurances. It also generates a small amount of revenue from risk management services. The firm act on behalf of its customers seeking insurance coverage from insurance companies. It generates revenue from the provision of insurance brokerage services.

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

Share on Social Networks: